Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$10.78 - $17.73 $153,464 - $252,404
14,236 New
14,236 $170,000
Q3 2022

Nov 14, 2022

BUY
$8.63 - $15.52 $121,286 - $218,118
14,054 New
14,054 $125,000
Q3 2021

Nov 15, 2021

SELL
$35.66 - $42.94 $745,579 - $897,789
-20,908 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$23.7 - $39.27 $495,519 - $821,057
20,908 New
20,908 $821,000

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.